2023 Q2 Form 10-Q Financial Statement

#000127344123000012 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $157.9M $144.2M $162.6M
YoY Change -23.27% -17.4% 11.18%
Cost Of Revenue $52.18M $44.44M $48.55M
YoY Change 24.22% 19.34% 14.04%
Gross Profit $105.7M $99.76M $114.1M
YoY Change -35.45% -27.36% 10.0%
Gross Profit Margin 66.95% 69.18% 70.15%
Selling, General & Admin $9.866M $12.70M $10.67M
YoY Change 0.31% 2.92% -4.65%
% of Gross Profit 9.33% 12.73% 9.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $56.21M $51.72M $51.78M
YoY Change 33.15% 26.26% 24.55%
% of Gross Profit 53.17% 51.85% 45.39%
Operating Expenses $66.07M $64.42M $62.45M
YoY Change 26.94% 20.86% 18.36%
Operating Profit $39.65M $35.34M $51.63M
YoY Change -64.52% -57.95% 1.35%
Interest Expense -$16.74M -$12.77M -$12.39M
YoY Change -16.68% -57.21% -64.36%
% of Operating Profit -42.22% -36.14% -24.0%
Other Income/Expense, Net $2.598M
YoY Change -6004.55%
Pretax Income $22.91M $23.18M $39.24M
YoY Change -75.0% -56.8% 139.52%
Income Tax $33.73M $32.88M $5.966M
% Of Pretax Income 147.26% 141.84% 15.2%
Net Earnings -$10.83M -$9.700M $33.28M
YoY Change -120.44% -168.7% -46.78%
Net Earnings / Revenue -6.86% -6.73% 20.46%
Basic Earnings Per Share -$0.33 -$0.03
Diluted Earnings Per Share -$0.33 -$0.03 $0.09
COMMON SHARES
Basic Shares Outstanding 368.9M shares 346.2M shares 368.9M shares
Diluted Shares Outstanding 33.30M shares 344.5M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.53M $105.7M $126.9M
YoY Change -36.87% 80.02% 385.94%
Cash & Equivalents $68.53M $105.7M $126.9M
Short-Term Investments
Other Short-Term Assets $9.108M $11.68M $29.81M
YoY Change -67.57% -42.0% 79.49%
Inventory $22.53M $20.08M $20.19M
Prepaid Expenses
Receivables $6.753M $13.60M $10.71M
Other Receivables $82.00K $113.0K $54.00K
Total Short-Term Assets $108.1M $152.3M $168.6M
YoY Change -27.33% 10.17% 65.6%
LONG-TERM ASSETS
Property, Plant & Equipment $1.142B $1.125B $1.101B
YoY Change 9.87% 11.63% 10.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.717M $5.923M $15.34M
YoY Change -58.88% -71.75% 22.71%
Total Long-Term Assets $1.201B $1.174B $1.167B
YoY Change 8.48% 7.36% 7.33%
TOTAL ASSETS
Total Short-Term Assets $108.1M $152.3M $168.6M
Total Long-Term Assets $1.201B $1.174B $1.167B
Total Assets $1.309B $1.326B $1.336B
YoY Change 4.24% 7.67% 12.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $197.8M $182.8M $162.8M
YoY Change 20.7% 21.13% 11.96%
Accrued Expenses $7.800M $4.800M $4.800M
YoY Change 178.57% 65.52% 45.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $233.2M $260.8M $241.6M
YoY Change 10.68% 11.77% 5.99%
LONG-TERM LIABILITIES
Long-Term Debt $585.8M $581.4M $589.6M
YoY Change -1.69% -1.09% 0.37%
Other Long-Term Liabilities $8.131M $7.319M $6.989M
YoY Change 30.03% -0.69% 105.74%
Total Long-Term Liabilities $688.7M $667.8M $676.4M
YoY Change 2.22% -1.9% 2.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $233.2M $260.8M $241.6M
Total Long-Term Liabilities $688.7M $667.8M $676.4M
Total Liabilities $921.9M $928.6M $918.0M
YoY Change 4.24% 1.59% 3.5%
SHAREHOLDERS EQUITY
Retained Earnings -$877.3M -$866.4M -$856.7M
YoY Change -5.54% -11.74% -13.96%
Common Stock $10.24M $10.27M $10.27M
YoY Change -0.34% 0.0% 0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $38.04M $27.32M
YoY Change
Treasury Stock Shares
Shareholders Equity $387.4M $397.8M $417.6M
YoY Change
Total Liabilities & Shareholders Equity $1.309B $1.326B $1.336B
YoY Change 4.24% 7.67% 12.32%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$10.83M -$9.700M $33.28M
YoY Change -120.44% -168.7% -46.78%
Depreciation, Depletion And Amortization $56.21M $51.72M $51.78M
YoY Change 33.15% 26.26% 24.55%
Cash From Operating Activities $37.88M $49.25M $71.87M
YoY Change -73.55% -52.56% -32.21%
INVESTING ACTIVITIES
Capital Expenditures $65.57M $71.06M $72.89M
YoY Change -200.56% -271.3% -281.18%
Acquisitions
YoY Change
Other Investing Activities -$5.783M $14.87M $23.02M
YoY Change -145.3% -924.79% -21.21%
Cash From Investing Activities -$71.35M -$56.19M -$49.87M
YoY Change 36.08% 29.81% 352.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.435M -$16.10M -13.36M
YoY Change -83.98% -41.08% -83.98%
NET CHANGE
Cash From Operating Activities 37.88M $49.25M 71.87M
Cash From Investing Activities -71.35M -$56.19M -49.87M
Cash From Financing Activities -6.435M -$16.10M -13.36M
Net Change In Cash -39.91M -$20.82M 8.633M
YoY Change -178.89% -161.79% -25.35%
FREE CASH FLOW
Cash From Operating Activities $37.88M $49.25M $71.87M
Capital Expenditures $65.57M $71.06M $72.89M
Free Cash Flow -$27.69M -$21.81M -$1.022M
YoY Change -113.29% -115.01% -100.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001273441
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34018
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
GRAN TIERRA ENERGY INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0479924
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Centre Street S.E.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Calgary,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AB
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
T2G 1A6
CY2023Q1 dei City Area Code
CityAreaCode
403
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
265-3221
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
GTE
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
368904496 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144190000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
174569000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
41369000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
34935000 usd
CY2023Q1 gte Oil Pipelineand Trucking Costs
OilPipelineandTruckingCosts
3066000 usd
CY2022Q1 gte Oil Pipelineand Trucking Costs
OilPipelineandTruckingCosts
2834000 usd
CY2023Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
51721000 usd
CY2022Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
40963000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
475000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12696000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12336000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1702000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3725000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-21439000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1090000 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
11836000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
12128000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
121775000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
120910000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
768000 usd
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23183000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
53659000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17606000 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20827000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15277000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18713000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32883000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39540000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-9700000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
14119000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344513998 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
367386664 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
344513998 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
372375245 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105684000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126873000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13596000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10706000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
20075000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
20192000 usd
CY2023Q1 gte Taxes Receivable Current
TaxesReceivableCurrent
113000 usd
CY2022Q4 gte Taxes Receivable Current
TaxesReceivableCurrent
54000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
11681000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9620000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
152291000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
168587000 usd
CY2023Q1 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1036350000 usd
CY2022Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1000424000 usd
CY2023Q1 us-gaap Capitalized Costs Unproved Properties
CapitalizedCostsUnprovedProperties
63454000 usd
CY2022Q4 us-gaap Capitalized Costs Unproved Properties
CapitalizedCostsUnprovedProperties
74471000 usd
CY2023Q1 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1099804000 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1074895000 usd
CY2023Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
25319000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
26007000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1125123000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1100902000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11806000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22990000 usd
CY2023Q1 gte Taxes Receivable Noncurrent
TaxesReceivableNoncurrent
31273000 usd
CY2022Q4 gte Taxes Receivable Noncurrent
TaxesReceivableNoncurrent
27796000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5923000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15335000 usd
CY2023Q1 gte Total Other Long Term Assets
TotalOtherLongTermAssets
49002000 usd
CY2022Q4 gte Total Other Long Term Assets
TotalOtherLongTermAssets
66121000 usd
CY2023Q1 us-gaap Assets
Assets
1326416000 usd
CY2022Q4 us-gaap Assets
Assets
1335610000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
187598000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
167579000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
65202000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
58978000 usd
CY2023Q1 gte Share Based Compensation Arrangement Recorded Liability Fair Value Disclosure Current
ShareBasedCompensationArrangementRecordedLiabilityFairValueDisclosureCurrent
8011000 usd
CY2022Q4 gte Share Based Compensation Arrangement Recorded Liability Fair Value Disclosure Current
ShareBasedCompensationArrangementRecordedLiabilityFairValueDisclosureCurrent
15082000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
260811000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
241639000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
581391000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
589593000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5377000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28000 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
65159000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
63358000 usd
CY2023Q1 gte Sharebased Compensation Arrangement Recorded Liability Fair Value Disclosure Noncurrent
SharebasedCompensationArrangementRecordedLiabilityFairValueDisclosureNoncurrent
8592000 usd
CY2022Q4 gte Sharebased Compensation Arrangement Recorded Liability Fair Value Disclosure Noncurrent
SharebasedCompensationArrangementRecordedLiabilityFairValueDisclosureNoncurrent
16437000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7319000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6989000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
667838000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
676405000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
368898619 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
368898619 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
333069042 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
346151157 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
10272000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10272000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1291973000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1291354000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
38035000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
27317000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-866443000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-856743000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
397767000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
417566000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1326416000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1335610000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-9700000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
14119000 usd
CY2023Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
51721000 usd
CY2022Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
40963000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
475000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15277000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18713000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1500000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4557000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
781000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
887000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-514000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4839000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1090000 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 gte Derivative Gain Loss On Derivative Net1
DerivativeGainLossOnDerivativeNet1
0 usd
CY2022Q1 gte Derivative Gain Loss On Derivative Net1
DerivativeGainLossOnDerivativeNet1
-21439000 usd
CY2023Q1 gte Cash Settlement Of Financial Instruments
CashSettlementOfFinancialInstruments
0 usd
CY2022Q1 gte Cash Settlement Of Financial Instruments
CashSettlementOfFinancialInstruments
-8596000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Cash Paid To Settle
AssetRetirementObligationCashPaidToSettle
0 usd
CY2022Q1 us-gaap Asset Retirement Obligation Cash Paid To Settle
AssetRetirementObligationCashPaidToSettle
5000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1144000 usd
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
411000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
606000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
344000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
10763000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-16520000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49253000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103825000 usd
CY2023Q1 us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
71062000 usd
CY2022Q1 us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
41483000 usd
CY2023Q1 gte Increase Decreasein Investing Working Capital
IncreaseDecreaseinInvestingWorkingCapital
14871000 usd
CY2022Q1 gte Increase Decreasein Investing Working Capital
IncreaseDecreaseinInvestingWorkingCapital
-1803000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56191000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43286000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
50000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 gte Repayments Of Long Term Debt1
RepaymentsOfLongTermDebt1
0 usd
CY2022Q1 gte Repayments Of Long Term Debt1
RepaymentsOfLongTermDebt1
27525000 usd
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
4225000 usd
CY2022Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10718000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
980000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1105000 usd
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
777000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16098000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27320000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2214000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
478000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20822000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33697000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133358000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31404000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112536000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65101000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
397767000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317781000 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
Description of Business Gran Tierra Energy Inc. a Delaware corporation (the “Company” or “Gran Tierra”), is a publicly traded company focused on international oil and natural gas exploration and production with assets currently in Colombia and Ecuador.
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
4825625000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
4753661000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3700502000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3652759000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1125123000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1100902000 usd
CY2023Q1 gte Operating Leaseand Finance Lease Rightof Use Assetbefore Accumulated Amortization
OperatingLeaseandFinanceLeaseRightofUseAssetbeforeAccumulatedAmortization
38300000 usd
CY2023Q1 gte Operating Lease And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
24000000 usd
CY2022Q4 gte Operating Leaseand Finance Lease Rightof Use Assetbefore Accumulated Amortization
OperatingLeaseandFinanceLeaseRightofUseAssetbeforeAccumulatedAmortization
38900000 usd
CY2022Q4 gte Operating Lease And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
24600000 usd
CY2023Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
11651000 usd
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
10992000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
560258000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
568917000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
21133000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
20676000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
581391000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
589593000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4800000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4800000 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
11055000 usd
CY2022Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
11241000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
781000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
887000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
11836000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
12128000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
368898619 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
368898619 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17302860 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.15
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4010289 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.86
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13799 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.01
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1267481 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.47
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20031869 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.01
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4600000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
19500000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10500000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2023Q1 gte Revenue Information Used To Assess Variable Consideration Constraint Adjustment For Quality And Transportation
RevenueInformationUsedToAssessVariableConsiderationConstraintAdjustmentForQualityAndTransportation
0.22
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344513998 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
367386664 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12950523 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12950523 shares
CY2023Q1 gte Shares To Be Purchased From Proceeds Of Stock Options
SharesToBePurchasedFromProceedsOfStockOptions
0 shares
CY2022Q1 gte Shares To Be Purchased From Proceeds Of Stock Options
SharesToBePurchasedFromProceedsOfStockOptions
7961942 shares
CY2022Q1 gte Shares To Be Purchased From Proceeds Of Stock Options
SharesToBePurchasedFromProceedsOfStockOptions
7961942 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
344513998 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
372375245 shares
CY2023Q1 gte Debt Instrument Collateral Letters Of Credit And Other Credit Support Provided As Security
DebtInstrumentCollateralLettersOfCreditAndOtherCreditSupportProvidedAsSecurity
109600000 usd
CY2022Q1 gte Revenue Information Used To Assess Variable Consideration Constraint Adjustment For Quality And Transportation
RevenueInformationUsedToAssessVariableConsiderationConstraintAdjustmentForQualityAndTransportation
0.13
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3200000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.42
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.74
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17600000 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20800000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15300000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18700000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.42
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.74
CY2022Q4 gte Debt Instrument Collateral Letters Of Credit And Other Credit Support Provided As Security
DebtInstrumentCollateralLettersOfCreditAndOtherCreditSupportProvidedAsSecurity
111100000 usd
CY2023Q1 gte Prepaid Equity Forwards Notional Amount Shares
PrepaidEquityForwardsNotionalAmountShares
10000000 shares
CY2023Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
8900000 usd
CY2022Q4 gte Prepaid Equity Forwards Notional Amount Shares
PrepaidEquityForwardsNotionalAmountShares
16000000 shares
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
16000000 usd
CY2023Q1 gte Gain Loss On Prepaid Equity Forwards
GainLossOnPrepaidEquityForwards
-1700000 usd
CY2022Q1 gte Gain Loss On Prepaid Equity Forwards
GainLossOnPrepaidEquityForwards
7800000 usd
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-21400000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105684000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58707000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126873000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26109000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
392000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5710000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5252000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5343000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4903000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112536000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65101000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133358000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31404000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3022000 usd
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
10150000 usd
CY2023Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
0 usd
CY2022Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-3276000 usd
CY2023Q1 gte Increase Decrease Prepaid Equity Forward
IncreaseDecreasePrepaidEquityForward
-7806000 usd
CY2022Q1 gte Increase Decrease Prepaid Equity Forward
IncreaseDecreasePrepaidEquityForward
10982000 usd
CY2023Q1 gte Increase Decrease In Prepaid Expenses And Inventory
IncreaseDecreaseInPrepaidExpensesAndInventory
-740000 usd
CY2022Q1 gte Increase Decrease In Prepaid Expenses And Inventory
IncreaseDecreaseInPrepaidExpensesAndInventory
159000 usd
CY2023Q1 gte Increase Decrease In Accounts Payable And Accrued And Other Long Term Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLongTermLiabilities
-17252000 usd
CY2022Q1 gte Increase Decrease In Accounts Payable And Accrued And Other Long Term Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLongTermLiabilities
12021000 usd
CY2023Q1 gte Increase Decrease In Prepaid Taxes And Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInPrepaidTaxesAndIncomeTaxesPayableNetOfIncomeTaxesReceivable
965000 usd
CY2022Q1 gte Increase Decrease In Prepaid Taxes And Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInPrepaidTaxesAndIncomeTaxesPayableNetOfIncomeTaxesReceivable
22514000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
10763000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-16520000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14900000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1700000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8461000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9703000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
8781000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
10042000 usd
CY2023Q1 gte Liabilities Relatedto Property Plantand Equipment Net
LiabilitiesRelatedtoPropertyPlantandEquipmentNet
69989000 usd
CY2022Q1 gte Liabilities Relatedto Property Plantand Equipment Net
LiabilitiesRelatedtoPropertyPlantandEquipmentNet
28339000 usd

Files In Submission

Name View Source Status
0001273441-23-000012-index-headers.html Edgar Link pending
0001273441-23-000012-index.html Edgar Link pending
0001273441-23-000012.txt Edgar Link pending
0001273441-23-000012-xbrl.zip Edgar Link pending
a20230331-ex311.htm Edgar Link pending
a20230331-ex312.htm Edgar Link pending
a20230331-ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gte-20230331.htm Edgar Link pending
gte-20230331.xsd Edgar Link pending
gte-20230331_g1.jpg Edgar Link pending
gte-20230331_g2.jpg Edgar Link pending
gte-20230331_g3.jpg Edgar Link pending
gte-20230331_g4.jpg Edgar Link pending
gte-20230331_g5.jpg Edgar Link pending
gte-20230331_g6.jpg Edgar Link pending
gte-20230331_g7.jpg Edgar Link pending
gte-20230331_g8.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
gte-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gte-20230331_def.xml Edgar Link unprocessable
gte-20230331_lab.xml Edgar Link unprocessable
gte-20230331_pre.xml Edgar Link unprocessable
gte-20230331_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending